Protalix BioTherapeutics
PLX
#8648
Rank
S$0.10 B
Marketcap
$1.43
Share price
-4.35%
Change (1 day)
-38.70%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : S$58.65 M

According to Protalix BioTherapeutics 's latest financial reports the company has S$58.65 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$58.85 M97.92%
2022-12-31S$29.73 M-43.44%
2021-12-31S$52.57 M3.17%
2020-12-31S$50.95 M112.99%
2019-12-31S$23.92 M-53.55%
2018-12-31S$51.5 M-24.74%
2017-12-31S$68.43 M-25.28%
2016-12-31S$91.58 M-15.3%
2015-12-31S$0.10 B49.43%
2014-12-31S$72.36 M-33.91%
2013-12-31S$0.10 B71.94%
2012-12-31S$63.67 M82.1%
2011-12-31S$34.96 M-24.42%
2010-12-31S$46.26 M-59.49%
2009-12-31S$0.11 B86.44%
2008-12-31S$61.25 M-31.47%
2007-12-31S$89.37 M153.91%
2006-12-31S$35.19 M345.91%
2005-12-31S$7.89 M849.17%
2004-12-31S$0.83 M-33.23%
2003-12-31S$1.24 M-11.12%
2002-12-31S$1.4 M-17.32%
2001-12-31S$1.69 M-39.18%
2000-12-31S$2.78 M13.93%
1999-12-31S$2.44 M14.9%
1998-12-31S$2.12 M130.45%
1997-12-31S$0.92 M-13.59%
1996-12-31S$1.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.33 B 477.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.35 B 2,207.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.24 B 15,669.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.94 B 4,914.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel